International Journal of Clinical Research

Objective: To review and analyze the effect of salmeterol and fluticasone in patients with COPD in hospital. Methods: From January 2022 to January 2023, the patients with COPD in the hospital were studied and discussed, including 62 patients. They were randomly assigned to the control group (31 patients were treated with routine treatment) and the observation group (31 patients were treated with salmeterol and ticasone), and the relevant data were collected and sorted, and finally processed by statistics. Results: TThe treatment result data were processed by the statistical system, and the result P value was less than 0.05. The observation group had better data information on lung function indicators, quality of life, satisfaction, and other aspects. Conclusion: The use of salmeterol and fluticasone can contribute to the smooth development of chronic obstructive pulmonary disease treatment, have a positive impact on the improvement of patients symptoms, reduce the risk of abnormal fluctuations in lung function indicators, improve the quality of life of patients, provide patients with a more satisfactory treatment plan, and have important significance in improving the treatment effect.

Salmeterol and fluticasone; Chronic obstructive pulmonary disease; Lung function; Quality of life